NCT00802854View on ClinicalTrials.gov

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV

CompletedOBSERVATIONAL
Enrollment

244

Participants

Timeline

Start Date

March 2, 2012

Primary Completion Date

May 20, 2016

Study Completion Date

May 20, 2016

Conditions
CandidemiaOther Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis)
Trial Locations (10)

561-712

Chonbuk National University Hospital, Deokjin-gu

602-715

Dong-A University Hospital, Busan

Dong-A University Medical Center (Dong-A University Hospital), Busen

700-712

Keimyung University Dongsan Medical Center (KUDMC), Daegu

701-724

Daegu fatima hospital, Daegu

705-718

Daegu Catholic University Medical Center (DCUMC), Daegu

443-721

Ajou University Hospital, Gyeonggi-do

120-752

Severance Hospital, Yonsei University Health System, Seoul

131-795

Seoul Medical Center, Seoul

138-736

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY